2-Chloro-5-fluoropyridine | CAS:31301-51-6

We serve 2-Chloro-5-fluoropyridine CAS:31301-51-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Chloro-5-fluoropyridine

Chemical Name:2-Chloro-5-fluoropyridine
CAS.NO:31301-51-6
Synonyms:2-Chloro-5-fluoropyridine
2-chloro-5-fluoro-pyridine
Molecular Formula:C5H3ClFN
Molecular Weight:131.53500
 
Physical and Chemical Properties:
Density:1.297
Boiling point:74ºC
Flash point:108ºC
Index of Refraction:1.503
 
Specification:
Appearance:Colourless to yellow to tan liquid or solid
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2-Chloro-5-fluoropyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-chloro-5-fluoro-pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Chloro-5-fluoropyridine Use and application,2-Chloro-5-fluoropyridine technical grade,usp/ep/jp grade.


Related News: The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions.Pyridine-3-Sulfonyl Chloride manufacturer The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions.4-Chloro-1-Butene supplier The StartScore model was developed by the company’s in-house supply chain experts based on actual performance data.10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine vendor The StartScore model was developed by the company’s in-house supply chain experts based on actual performance data.Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase.